Literature DB >> 6610939

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine destroys dopamine neurons in explants of rat embryo mesencephalon.

C Mytilineou, G Cohen.   

Abstract

Explants of embryonic rat mesencephalon were grown in organotypic culture. Addition of 10 microM 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to the culture medium for 4 to 7 days resulted in loss of dopamine cell bodies and fiber outgrowths, as observed by fluorescence histochemistry. At the same time, the cultures showed decreased uptake of tritium-labeled dopamine. However, no signs of generalized toxicity were evident when the explant cultures were viewed by light and phase-contrast microscopy. These results show that MPTP exerts a relatively selective destructive action in dopamine neurons in vitro, similar to the action observed in humans and monkeys in vivo. Pargyline (10 microM), a monoamine oxidase inhibitor, protected the dopamine neurons in the explants. Organotypic cultures provide an experimental model for the study of the properties of MPTP in vitro.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6610939     DOI: 10.1126/science.6610939

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  10 in total

1.  Selective decrease of immunoreactive tyrosine hydroxylase in nigrostriatum of adult male rats after N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.

Authors:  L L Vacca-Galloway; R Ikeda; S Y Coleman
Journal:  Cell Tissue Res       Date:  1988-07       Impact factor: 5.249

2.  The interaction of 1-alkyl-4,4-diphenylpiperidines with the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine receptor binding site.

Authors:  H Russ; U Pindur; H Przuntek
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

3.  Enzymic sulphation of dopa and tyrosine isomers by HepG2 human hepatoma cells: stereoselectivity and stimulation by Mn2+.

Authors:  M Suiko; Y Sakakibara; H Nakajima; H Sakaida; M C Liu
Journal:  Biochem J       Date:  1996-02-15       Impact factor: 3.857

4.  An in vitro model of 1-methyl-4-phenyl-pyridinium (MPP+) toxicity: incubation of rabbit caudate nucleus slices with MPP+ followed by biochemical and functional analysis.

Authors:  T J Feuerstein; L Hedler; R Jackisch; G Hertting
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

5.  Automated imaging system for fast quantitation of neurons, cell morphology and neurite morphometry in vivo and in vitro.

Authors:  Victor Tapias; J Timothy Greenamyre; Simon C Watkins
Journal:  Neurobiol Dis       Date:  2012-12-07       Impact factor: 5.996

6.  Prevention of dopaminergic toxicity of MPTP in mice by phenylethylamine, a specific substrate of type B monoamine oxidase.

Authors:  E Melamed; M B Youdim
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

7.  Deprenyl in Parkinson disease: personal experience.

Authors:  P Giovannini; M P Grassi; G Scigliano; I Piccolo; P Soliveri; T Caraceni
Journal:  Ital J Neurol Sci       Date:  1985-06

8.  Functional changes in cocultures of mesencephalon and striatal neurons from embryonic C57/BL6 mice due to low concentrations of 1-methyl-4-phenylpyridinium (MPP+).

Authors:  E Koutsilieri; W W Chan; D Reinitzer; W D Rausch
Journal:  J Neural Transm Gen Sect       Date:  1993

9.  The Neurotoxin l-Methyl-4-Phenyl-l,2,3,6-Tetrahydropyridine (MPTP): A Key to Parkinson's Disease?

Authors:  I Irwin
Journal:  Pharm Res       Date:  1986-02       Impact factor: 4.200

Review 10.  MPTP: an industrial chemical and contaminant of illicit narcotics stimulates a new era in research on Parkinson's disease.

Authors:  I J Kopin
Journal:  Environ Health Perspect       Date:  1987-11       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.